4.6 Article Proceedings Paper

Use of progression-free survival as a surrogate marker in oncology trials: some regulatory issues

Related references

Note: Only part of the references are listed.
Article Oncology

Sorafenib for the treatment of advanced renal cell carcinoma

Robert C. Kane et al.

CLINICAL CANCER RESEARCH (2006)

Review Oncology

Accelerated approval of oncology products: A decade of experience

R Dagher et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)

Article Oncology

End points and United States food and drug administration approval of oncology drugs

JR Johnson et al.

JOURNAL OF CLINICAL ONCOLOGY (2003)